Anabolic Resistance Does Not Explain Sarcopenia in Patients With Type 2 Diabetes Mellitus, Compared With Healthy Controls, Despite Reduced mTOR Pathway Activity

Clinical Nutrition - United States
doi 10.1016/j.clnu.2016.11.012
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Blood Fibrinolytic Activity in Patients With Type 2 Diabetes Mellitus Associated With Hypothyroidism

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY
2015English

Risk Factors in Patients With Type 2 Diabetes Mellitus

Revista Latino-Americana de Enfermagem
Nursing
2008English

Sitagliptin Improves Albuminuria in Patients With Type 2 Diabetes Mellitus

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2013English

Detection of OSA in Patients With Type 2 Diabetes Mellitus

International Journal of Diabetes & Metabolic Disorders
2018English

Association of Decreased Handgrip Strength With Reduced Cortical Thickness in Japanese Female Patients With Type 2 Diabetes Mellitus

Scientific Reports
Multidisciplinary
2018English

Combined Atherosclerotic Lesions in Patients With Type 2 Diabetes Mellitus

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY
2016English

Silent Myocardial Ischemia in Patients With Diabetes Mellitus Type 2

Zaporozhye Medical Journal
2015English

Pharmacists Intervention Reduced Drug-Related Problems in the Treatment of Patients With Type 2 Diabetes Mellitus

Open Access Macedonian Journal of Medical Sciences
Medicine
2019English

Color Space Distortions in Patients With Type 2 Diabetes Mellitus

Visual Neuroscience
Sensory SystemsPhysiology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy